Developer docs
API playgroundTry for free, no card

Search company profiles

Niche Science & Technology

Full company profile

uuid000zzjx

Namestring
Niche Science & Technology
Legal namestring
Niche Science & Technology Ltd
Websiteurl
niche.org.uk
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Niche Science & Technology Ltd is a UK-based specialist clinical research organisation founded in 1998, providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations. The company operates from Richmond, London (with a registered office in Hyde, Cheshire) and delivers three core service pillars: Clinical Operations (clinical project management, trial master file management, study monitoring, site management), Regulatory Affairs (regulatory writing, strategy development, agency communications and submissions, QC review, legal representation), and Medical Communications (strategic communications, medical education, publication planning, medical illustration, grant applications). It also offers a branded offering called BioStack™. Services span from first-in-human studies through to marketing authorisation applications and publication planning, with documented contributions to EMA, FDA, MHRA and Health Canada approvals — including the world's first ex vivo autologous gene therapy (Strimvelis) and the antibiotic lefamulin.

The company's go-to-market is direct B2B enterprise engagement, with no reseller or marketplace channels. Lead generation is supported by a content-led strategy including the Insider's Insights practical guidance library, podcasts, case histories, and a free 48-hour Investigator Brochure review service personally delivered by Dr. Tim Hardman. Pricing is not publicly disclosed and is negotiated on a per-project basis. Customers span small and mid-size biotechs, larger pharmaceutical sponsors (ViiV Healthcare, Adaptimmune, Erytech, Nabriva, Orchard Therapeutics, Astex, Petrovax, EVERSANA), medical device firms (Cardionetics, ApaTech), academic research consortia (RASP-UK, MID-Frail, FRAILomic), and professional associations (British Society for Haematity). Several relationships exceed ten years in duration, indicating high retention. The company also manages large research consortia such as the £9.6 million MRC-funded RASP-UK initiative (since 2014) and rescued the €6 million EU Horizon 2020 MID-Frail study after the original CRO withdrew.

The firm operates as an independent, privately-held private limited company with 11-50 employees and no disclosed external funding, parent entity, or institutional investment. Geographic reach spans the UK and broader Europe (Ireland, France, Switzerland, Austria, Sweden, Germany, Belgium) with selected North American engagements, but no formal global footprint claim. The business model is professional services revenue earned through project-based contracts tied to clinical development programmes.

Short descriptiontext

Niche Science & Technology is a UK-based specialist clinical research organisation providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations across the UK and Europe since 1998.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRichmond, United Kingdom
HQ citystring
Richmond
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research organization, medical writing services, regulatory affairs consulting, clinical trial management, regulatory submissions support
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Project-based professional services providing specialist medical writing, regulatory strategy and clinical operations support to biotechnology companies, pharmaceutical sponsors and research organisations. Revenue is generated through service contracts for clinical development programmes from first-in-human studies through to regulatory submissions and publication planning.

niche.org.uk
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1BioStack™
Description

A product/service offering by Niche Science & Technology, referenced on the company's website navigation.

niche.org.uk
Core offering1 text field

Niche Science & Technology is a specialist clinical research organisation (CRO) that provides medical writing, regulatory strategy, and clinical operations support to biotechnology companies, pharmaceutical sponsors, and research organisations. Services span from first-in-human studies through to regulatory submissions and publication planning, with deep expertise across UK and European regulatory frameworks including EMA, FDA, MHRA, and Health Canada. The company also offers a proprietary branded platform called BioStack™.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Supported Strimvelis to become world's first ex vivo autologous gene therapy to gain regulatory approval (EMA)
+3 more records
Product overview1 text field

Niche Science & Technology is a specialist clinical research organisation (CRO) providing medical writing and clinical research support services. The company operates as a service-based organisation rather than a software product company, offering three core service pillars: Clinical Operations, Regulatory Affairs, and Medical Communications. These services are delivered through a multidisciplinary team combining scientific depth with operational precision. The company also offers a branded product called BioStack™. Services span from first-in-human studies to publication planning and regulatory submissions, supporting biotechnology companies, pharmaceutical sponsors, and research organisations across the UK and Europe.

Product and service4 records
1Clinical Operations
CategoryCore service
Description

Comprehensive clinical operations support covering clinical project management, trial master file and document management, study monitoring and site management, study documents, and quality and vendor management systems for biotechnology and pharmaceutical sponsors running clinical development programmes.

2Regulatory Affairs
CategoryCore service
Description

Regulatory strategy and writing services including regulatory writing, regulatory strategy development, agency communications and submissions, QC review and redaction, and legal representation for clinical development programmes.

3Medical Communications
CategoryCore service
Description

Strategic medical communications including strategic communications, medical education, editorial and quality control services, publication planning, medical illustration, and grant applications for clinical development sponsors.

4BioStack™
CategoryProprietary product
Description

A proprietary branded platform or methodology referenced in the company's service portfolio, positioned as a specialised product offering for clinical research or document management.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeOthersAnnounced on2024-01-01
Description

P95, a global CRO headquartered in Belgium, acquired Assign DMB (Niche's long-term client partner) in 2024, integrating their expertise with P95's global capabilities for epidemiology and clinical solutions.

Strategic tierMinorTypeOthersAnnounced on2022-01-01
Description

Cytel Inc. acquired Scandinavian Development Services in 2022. Niche had partnered with SDS since 2013 providing regulatory writing services for Nordic clients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

MRC co-funded the RASP-UK initiative with £9.6 million investment alongside Asthma UK and pharmaceutical partners. Niche has run the executive function of this consortium since 2014, overseeing seven clinical trials across 13 academic centres for severe asthma research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

Co-funder of the £9.6 million RASP-UK consortium alongside MRC. Partnership focused on transforming management of severe asthma through personalised treatment approaches and biomarker research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers33 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Niche Science & Technology

Clinical Research Organization (CRO) Servicesniche.org.uk

Niche Science & Technology is a UK-based specialist clinical research organisation providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations across the UK and Europe since 1998.

What Niche Science & Technology does

Niche Science & Technology Ltd is a UK-based specialist clinical research organisation founded in 1998, providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations. The company operates from Richmond, London (with a registered office in Hyde, Cheshire) and delivers three core service pillars: Clinical Operations (clinical project management, trial master file management, study monitoring, site management), Regulatory Affairs (regulatory writing, strategy development, agency communications and submissions, QC review, legal representation), and Medical Communications (strategic communications, medical education, publication planning, medical illustration, grant applications). It also offers a branded offering called BioStack™. Services span from first-in-human studies through to marketing authorisation applications and publication planning, with documented contributions to EMA, FDA, MHRA and Health Canada approvals — including the world's first ex vivo autologous gene therapy (Strimvelis) and the antibiotic lefamulin.

The company's go-to-market is direct B2B enterprise engagement, with no reseller or marketplace channels. Lead generation is supported by a content-led strategy including the Insider's Insights practical guidance library, podcasts, case histories, and a free 48-hour Investigator Brochure review service personally delivered by Dr. Tim Hardman. Pricing is not publicly disclosed and is negotiated on a per-project basis. Customers span small and mid-size biotechs, larger pharmaceutical sponsors (ViiV Healthcare, Adaptimmune, Erytech, Nabriva, Orchard Therapeutics, Astex, Petrovax, EVERSANA), medical device firms (Cardionetics, ApaTech), academic research consortia (RASP-UK, MID-Frail, FRAILomic), and professional associations (British Society for Haematity). Several relationships exceed ten years in duration, indicating high retention. The company also manages large research consortia such as the £9.6 million MRC-funded RASP-UK initiative (since 2014) and rescued the €6 million EU Horizon 2020 MID-Frail study after the original CRO withdrew.

The firm operates as an independent, privately-held private limited company with 11-50 employees and no disclosed external funding, parent entity, or institutional investment. Geographic reach spans the UK and broader Europe (Ireland, France, Switzerland, Austria, Sweden, Germany, Belgium) with selected North American engagements, but no formal global footprint claim. The business model is professional services revenue earned through project-based contracts tied to clinical development programmes.

Niche Science & Technology firmographics

Firmographics
Name
Niche Science & Technology
Legal name
Niche Science & Technology Ltd
Website
https://niche.org.uk
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
11–50 employees
Short description
Niche Science & Technology is a UK-based specialist clinical research organisation providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations across the UK and Europe since 1998.
Ownership category
akta.pro rank

Niche Science & Technology industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Keywords

  • Clinical research organization
  • Medical writing services
  • Regulatory affairs consulting
  • Clinical trial management
  • Regulatory submissions support

Where Niche Science & Technology is headquartered

Location

Headquarters

HQ city
Richmond
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Niche Science & Technology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Clinical Research Services: Project-based professional services providing specialist medical writing, regulatory strategy and clinical operations support to biotechnology companies, pharmaceutical sponsors and research organisations. Revenue is generated through service contracts for clinical development programmes from first-in-human studies through to regulatory submissions and publication planning.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Niche Science & Technology product offering

Product offering

Core offering

Niche Science & Technology is a specialist clinical research organisation (CRO) that provides medical writing, regulatory strategy, and clinical operations support to biotechnology companies, pharmaceutical sponsors, and research organisations. Services span from first-in-human studies through to regulatory submissions and publication planning, with deep expertise across UK and European regulatory frameworks including EMA, FDA, MHRA, and Health Canada. The company also offers a proprietary branded platform called BioStack™.

Product overview

Niche Science & Technology is a specialist clinical research organisation (CRO) providing medical writing and clinical research support services. The company operates as a service-based organisation rather than a software product company, offering three core service pillars: Clinical Operations, Regulatory Affairs, and Medical Communications. These services are delivered through a multidisciplinary team combining scientific depth with operational precision. The company also offers a branded product called BioStack™. Services span from first-in-human studies to publication planning and regulatory submissions, supporting biotechnology companies, pharmaceutical sponsors, and research organisations across the UK and Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • BioStack™: A product/service offering by Niche Science & Technology, referenced on the company's website navigation.

Products and services

  • Clinical Operations Comprehensive clinical operations support covering clinical project management, trial master file and document management, study monitoring and site management, study documents, and quality and vendor management systems for biotechnology and pharmaceutical sponsors running clinical development programmes.
  • Regulatory Affairs Regulatory strategy and writing services including regulatory writing, regulatory strategy development, agency communications and submissions, QC review and redaction, and legal representation for clinical development programmes.
  • Medical Communications Strategic medical communications including strategic communications, medical education, editorial and quality control services, publication planning, medical illustration, and grant applications for clinical development sponsors.
  • BioStack™ A proprietary branded platform or methodology referenced in the company's service portfolio, positioned as a specialised product offering for clinical research or document management.

Quantifiable outcome

  • Supported Strimvelis to become world's first ex vivo autologous gene therapy to gain regulatory approval (EMA)
  • +3 more outcomes

Companies that use Niche Science & Technology

Customer profile

Named customers33 records

Segments4 records

Ideal customer profiles3 records

Niche Science & Technology technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Niche Science & Technology partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and core.

  • P95minorOthers · 1 January 2024P95, a global CRO headquartered in Belgium, acquired Assign DMB (Niche's long-term client partner) in 2024, integrating their expertise with P95's global capabilities for epidemiology and clinical solutions.
  • Cytel Inc.minorOthers · 1 January 2022Cytel Inc. acquired Scandinavian Development Services in 2022. Niche had partnered with SDS since 2013 providing regulatory writing services for Nordic clients.
  • Medical Research Council (MRC)coreStrategic or Co-development Partner · 1 January 2014MRC co-funded the RASP-UK initiative with £9.6 million investment alongside Asthma UK and pharmaceutical partners. Niche has run the executive function of this consortium since 2014, overseeing seven clinical trials across 13 academic centres for severe asthma research.
  • Asthma UKcoreStrategic or Co-development Partner · 1 January 2014Co-funder of the £9.6 million RASP-UK consortium alongside MRC. Partnership focused on transforming management of severe asthma through personalised treatment approaches and biomarker research.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Niche Science & Technology competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Niche Science & Technology social profiles

Digital presence

Niche Science & Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Niche Science & Technology leadership team

Management profile

Number of profiles

Profiles1 record

Niche Science & Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Niche Science & Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Niche Science & Technology

What does Niche Science & Technology do?

Niche Science & Technology is a specialist clinical research organisation (CRO) that provides medical writing, regulatory strategy, and clinical operations support to biotechnology companies, pharmaceutical sponsors, and research organisations. Services span from first-in-human studies through to regulatory submissions and publication planning, with deep expertise across UK and European regulatory frameworks including EMA, FDA, MHRA, and Health Canada. The company also offers a proprietary branded platform called BioStack™.

Is Niche Science & Technology a public or private company?

Niche Science & Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Niche Science & Technology founded?

Niche Science & Technology was founded in 1998. It employs 11 to 50 people.

Where is Niche Science & Technology based?

Niche Science & Technology is headquartered in Richmond, United Kingdom, in the Europe region.

How does Niche Science & Technology make money?

One revenue line is on record: clinical Research Services.

Does Niche Science & Technology have an API?

No public API is recorded for Niche Science & Technology.

What industry is Niche Science & Technology in?

Niche Science & Technology's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales